Table 1.
Baseline characteristics of the participants to the study hospitalized for an acute coronary syndrome in 4 academic centers in Switzerland from September 2009 to October 2010.
Figure 1.
Percent of participants with recommended treatment at discharge taking into account reported reasons for non-prescription.
Abbreviations: P2Y12 inhibitors: clopidogrel, prasugrel or ticagrelor; ACEI/ATII : Angiotensin converting enzyme inhibitor/angiotensin II receptor blockers. * P2Y12 inhibitors if PCI-stent treatment (n = 1066). ** ACEI/ATII inhibitors if left ventricular ejection fraction (LVEF) ≤40% (n = 220).
Table 2.
Documented Treatment at Discharge for participants hospitalized for an acute coronary syndrome in 4 academic centers Switzerland from Sept 2009 to October 2010.
Table 3.
Documented reasons for not prescribing recommended cardiovascular medication at discharge.